NHS
Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma
February 11, 2020Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma
Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …
NICE plans to use broader range of data in guidance
February 5, 2020Research and Development NHS, NHS NICE, NICE
The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …
NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”
January 31, 2020Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma
NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …
Top Ten most popular articles on Pharmafile.com this week
January 31, 2020Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …
Read the January/February 2020 edition of Pharmafocus online now!
January 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression
January 28, 2020Manufacturing and Production, Sales and Marketing Janssen, NHS, NICE, Spravato, depression
Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …
NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use
January 27, 2020Sales and Marketing NHS, NICE, Novo Nordisk, UK, obesity, saxenda
NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …
UK tests 14 people for Chinese coronavirus
January 24, 2020Medical Communications Chinese Coronavirus, NHS, Public Health England, Viral outbreaks, Viral pnemonia, coronavirus, epidemic
14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE). In Scotland, …
NICE declines to recommend Astellas’ Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia
January 23, 2020Sales and Marketing Astellas, NHS, NICE, UK, Xospata, acute myeloid leukaemia
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the …
Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults
January 21, 2020Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …
Novartis’ Mayzent granted license by the European Medicines Agency
January 21, 2020Manufacturing and Production CNS, European Medicines Agency, NHS, NICE, Novartis
The European Medicines Agency (EMA) has granted a licence for the use of Mayzent (siponimod) in the treatment of certain …
Lynparza tablets approved for NHS use in platinum-sensitive, BRCA-mutated ovarian, fallopian tube or peritoneal cancer
January 16, 2020Sales and Marketing AstraZeneca, MSD, NHS, NICE, UK, lynparza
It has been announced that tablet form of Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has secured …
HIV infections fall by 73% in bi and gay British men
January 16, 2020Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …
NICE shoots down Keytruda in head and neck cancer over data concerns
January 16, 2020Sales and Marketing Cancer, NHS, NICE, UK, keytruda, pharma
It has been revealed that NICE has chosen to reject MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) for routine use on the …
NHS to pioneer Novartis injection that reduces cholesterol
January 14, 2020Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack
The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …
